- Home
- / Suven Life Sciences
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Suven Life Sciences financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
₹118.1
2024-10-29
Market Capitalization
₹28.4 B
2024-10-29
Revenue
₹71.1 M
FY, 2026
CreditSafe Score
?
Score changed on Jun 06, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| INR | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 | FY, 2026 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 6.1B | 2.8B | 144.1M | 134.8M | 118.4M | 135.4M | 116.9M | 66.6M | 71.1M |
| Cost of goods sold | 1.6B | 708.8M | 328.0K | 1.6M | 3.7M | 7.2M | 10.4M | ||
| Gross profit | 4.7B | 2.2B | 147.4M | 141.0M | 158.7M | 152.0M | 111.3M | 58.6M | 210.4M |
| Gross profit margin, % | 78.0% | 102.2% | 104.6% | 134.0% | 112.3% | 95.2% | 88.0% | 295.8% | |
| Operating expense total | 2.7B | 2.3B | 1.3B | 929.7M | 1.3B | 1.4B | 1.4B | 1.7B | 2.9B |
| Depreciation and amortization | 247.6M | 142.0M | 41.7M | 43.5M | 43.9M | 65.4M | 65.0M | 58.2M | 56.1M |
| EBITDA | 2.0B | (106.0M) | (1.2B) | (788.7M) | (1.2B) | (1.2B) | (1.3B) | (1.7B) | (2.7B) |
| EBITDA margin, % | -3.8% | -799.2% | -585.2% | -992.9% | -910.5% | -1091.5% | -2481.8% | -3803.0% | |
| EBIT | 1.8B | (247.9M) | (1.2B) | (832.2M) | (1.2B) | (1.2B) | (1.3B) | (1.7B) | (2.8B) |
| EBIT margin, % | -9.0% | -828.1% | -617.4% | -1030.0% | -914.5% | -1083.4% | -2569.3% | -3881.9% | |
| Interest income | 8.9M | 11.1M | 132.1M | 69.8M | 11.3M | 64.2M | 164.3M | 56.8M | |
| Interest expense | 46.3M | 19.1M | 5.5M | 9.4M | 6.7M | 5.4M | 3.0M | 1.7M | 1.6M |
| Pre tax profit | 2.0B | 1.6M | (1.1B) | (774.7M) | (1.2B) | (1.2B) | (1.1B) | (1.6B) | (2.8B) |
| Income tax expense | 718.4M | 240.6M | (121.8M) | (53.2M) | (10.0M) | ||||
| Net Income | 1.2B | (239.0M) | (942.2M) | (721.5M) | (1.2B) | (1.2B) | (1.1B) | (1.6B) | (2.8B) |